Stay updated on VTX958 vs Placebo in Psoriasis Treatment Clinical Trial
Sign up to get notified when there's something new on the VTX958 vs Placebo in Psoriasis Treatment Clinical Trial page.

Latest updates to the VTX958 vs Placebo in Psoriasis Treatment Clinical Trial page
- Check6 days agoChange DetectedAdded a detailed Locations section listing study sites by state (AL, AZ, AR, CA, FL, GA, IN, KY, MD, MA, MI, MN, MO, NH, NC, OH, OR, SD, TN, TX, WA) and updated the record to Revision v3.3.3. Removed the HHS Vulnerability Disclosure element.SummaryDifference2%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check28 days agoChange DetectedRevision tag on the page changed to v3.3.2, replacing the previous v3.3.1.SummaryDifference0.0%

- Check35 days agoChange DetectedPage history shows a revision from v3.2.0 to v3.3.1. This appears to be a metadata update with no visible changes to the study data or criteria.SummaryDifference0.0%

- Check42 days agoChange DetectedRemoved the government funding status notice about potential delays and operating status from the page; core study details and enrollment information remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check56 days agoChange DetectedNo additions or deletions detected; the study record content appears unchanged.SummaryDifference0.3%

- Check85 days agoChange DetectedUpdate includes a critical operating status notice and a new software version (v3.2.0), indicating updated deployment with potential service impact; previous version reference (v3.1.0) was removed.SummaryDifference3%

Stay in the know with updates to VTX958 vs Placebo in Psoriasis Treatment Clinical Trial
Enter your email address, and we'll notify you when there's something new on the VTX958 vs Placebo in Psoriasis Treatment Clinical Trial page.